MusclePharm Corporation

Equities

MSLP

US6273352012

Investment Holding Companies

Market Closed - OTC Markets Other stock markets 09:47:02 01/07/2024 pm IST			5-day change	1st Jan Change
0.000025 ^USD	+2,400.00%		0.00%	+2,400.00%

2023	Second Motion for Exclusivity Period Extension Approved For MusclePharm Corporation	CI
2023	FitLife Brands, Inc. completed the acquisition of Substantially all of the assets of MusclePharm Corporation (OTCPK:MSLP.Q).	CI

MUSCLEPHARM CORP : Change in Directors or Principal Officers (form 8-K)

January 08, 2021 at 04:35 pm IST

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

On December 31, 2020, William Bush submitted his resignation from the Board of Directors of MusclePharm Corporation and all committees on which he served, effective the date thereof.

Latest news about MusclePharm Corporation

Second Motion for Exclusivity Period Extension Approved For MusclePharm Corporation	18/23/18	CI
FitLife Brands, Inc. completed the acquisition of Substantially all of the assets of MusclePharm Corporation (OTCPK:MSLP.Q).	10/23/10	CI
Motion for Asset Sale Approved for MusclePharm Corporation	03/23/03	CI
FitLife Brands, Inc. entered into an agreement to acquire Substantially all of the assets of MusclePharm Corporation (OTCPK:MSLP.Q) for $18.3 million.	27/23/27	CI
Stalking Horse Agreement Filed by MusclePharm Corporation	08/23/08	CI
Musclepharm Corporation Announces Resignation of Paul Karr as Director	01/23/01	CI
Second Amended Reorganization Plan and Disclosure Statement Filed by MusclePharm Corporation	28/23/28	CI
First Amended Disclosure Statement Approved for MusclePharm Corporation	28/23/28	CI
Bidding Procedure Approved for MusclePharm Corporation	17/23/17	CI
Musclepharm Corporation Terminates Gary Shirshac as Chief Financial Officer	20/23/20	CI
First Amended Reorganization Plan and DIsclosure Statement Filed by MusclePharm Corporation	19/23/19	CI
Reorganization Plan and Disclosure Statement Filed by MusclePharm Corporation	26/23/26	CI
Motion for Asset Sale Filed by MusclePharm Corporation	12/23/12	CI
First Motion for Exclusivity Period Extension Approved For MusclePharm Corporation	10/23/10	CI
MusclePharm Corporation has withdrawn its IPO in the amount of $10 million.	16/23/16	CI
First Motion for Exclusivity Period Extension Filed by MusclePharm Corporation	10/23/10	CI
DIP Financing Approved for MusclePharm Corporation	08/23/08	CI
Amended DIP Financing Approved for MusclePharm Corporation	23/23/23	CI
Interim DIP Financing Approved for MusclePharm Corporation	09/23/09	CI
MusclePharm Corporation Filed for Bankruptcy	15/22/15	CI
MusclePharm Appoints Gary C. Shirshac as Interim CFO	30/22/30	MT
MusclePharm Corporation Appoints Gary C. Shirshac to Serve as Interim Chief Financial Officer	30/22/30	CI
MusclePharm Chief Financial Officer Eric Chin Resigns	24/22/24	MT
MusclePharm Corporation Announces Appointment of Eric Chin as Chief Financial Officer of the Company	29/22/29	CI
MusclePharm Corporation Announces Board Changes	29/22/29	CI

Chart MusclePharm Corporation

Duration

Period

More charts

Company Profile

MusclePharm Corporation is a United States company. The Company has no operation nor generated any revenue.

Sector

Investment Holding Companies

More about the company

Sector Shell Companies

	1st Jan change	Capi.
MUSCLEPHARM CORPORATION	+2,400.00%	836
CHURCHILL CAPITAL CORP VII	+2.67%	99Cr
PERELLA WEINBERG PARTNERS	+49.30%	96Cr
ARES ACQUISITION CORPORATION II	+2.49%	67Cr
DA ZHONG TRADING GROUP HOLDING COMPANY	-.--%	60Cr
E7 GROUP	-2.15%	58Cr
ADMIRAL ACQUISITION LIMITED	+10.28%	54Cr
CAPITOL INVESTMENT CORP. VII	-.--%	50Cr
AEA-BRIDGES IMPACT CORP.	+8.04%	47Cr
DONG FANG HUI LE INC.	-.--%	45Cr

Shell Companies